Actively Recruiting
Multi-Omics for Maternal Health After Preeclampsia
Led by University of California, San Diego · Updated on 2025-04-06
1100
Participants Needed
1
Research Sites
258 weeks
Total Duration
On this page
Sponsors
U
University of California, San Diego
Lead Sponsor
N
National Human Genome Research Institute (NHGRI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
To develop strategies to identify postpartum women at risk for adverse cardiovascular outcomes and provide them with preventative therapies.
CONDITIONS
Official Title
Multi-Omics for Maternal Health After Preeclampsia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pregnant women aged 18 to 50 years
- Between 10 and 24 weeks of gestation at enrollment
- Singleton pregnancy
- Planning to deliver at a study site (UCSD or VUMC)
You will not qualify if you...
- Unable to give informed consent
- Intrauterine fetal death
- Fetal genetic or structural abnormality
- Institutionalized for psychiatric disorder, mental deficiency, or incarcerated
- Active or past malignancy requiring major surgery or systemic chemotherapy
- Multiple pregnancies or twin demise at any gestational age
- Known maternal or fetal chromosomal abnormalities
- Planning to keep the placenta after delivery
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of California, San Diego
San Diego, California, United States, 92037
Actively Recruiting
Research Team
M
Maya Selvaraj
CONTACT
V
Valentina Stanley
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here